Search Results
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Ploutarchos Tzoulis in
Google Scholar
PubMed
Search for other papers by Marina Tsoli in
Google Scholar
PubMed
Search for other papers by Eleftherios Chatzellis in
Google Scholar
PubMed
Search for other papers by Anna Koumarianou in
Google Scholar
PubMed
Search for other papers by Gregory Kaltsas in
Google Scholar
PubMed
relatively rare neuroendocrine neoplasms (NEN) associated in 25–30% with somatic mutations when sporadic, whereas 35% are familial associated with germline mutations in over 20 susceptibility genes ( Gupta et al. 2017 ) Up to 20% of PC/PGL are metastatic
Search for other papers by S L Asa in
Google Scholar
PubMed
Search for other papers by O Casar-Borota in
Google Scholar
PubMed
Search for other papers by P Chanson in
Google Scholar
PubMed
Search for other papers by E Delgrange in
Google Scholar
PubMed
Search for other papers by P Earls in
Google Scholar
PubMed
Search for other papers by S Ezzat in
Google Scholar
PubMed
Search for other papers by A Grossman in
Google Scholar
PubMed
Search for other papers by H Ikeda in
Google Scholar
PubMed
Search for other papers by N Inoshita in
Google Scholar
PubMed
Search for other papers by N Karavitaki in
Google Scholar
PubMed
Search for other papers by M Korbonits in
Google Scholar
PubMed
Search for other papers by E R Laws Jr in
Google Scholar
PubMed
Search for other papers by M B Lopes in
Google Scholar
PubMed
Search for other papers by N Maartens in
Google Scholar
PubMed
Search for other papers by I E McCutcheon in
Google Scholar
PubMed
Search for other papers by O Mete in
Google Scholar
PubMed
Search for other papers by H Nishioka in
Google Scholar
PubMed
Search for other papers by G Raverot in
Google Scholar
PubMed
Search for other papers by F Roncaroli in
Google Scholar
PubMed
Search for other papers by W Saeger in
Google Scholar
PubMed
Search for other papers by L V Syro in
Google Scholar
PubMed
Search for other papers by A Vasiljevic in
Google Scholar
PubMed
Search for other papers by C Villa in
Google Scholar
PubMed
Search for other papers by A Wierinckx in
Google Scholar
PubMed
Search for other papers by J Trouillas in
Google Scholar
PubMed
Search for other papers by and the attendees of 14th Meeting of the International Pituitary Pathology Club, Annecy, France, November 2016 in
Google Scholar
PubMed
gastrointestinal and respiratory tracts. Over the last two decades, there have been terminology shifts that reflect the potential for malignant behavior of even the most bland of those neuroendocrine neoplasms. They evolved from ‘adenoma’ to ‘tumor’ to recognize
Search for other papers by Tessa Brabander in
Google Scholar
PubMed
Department of Molecular Genetics, Erasmus Medical Center, Rotterdam, The Netherlands
Search for other papers by Julie Nonnekens in
Google Scholar
PubMed
Search for other papers by Johannes Hofland in
Google Scholar
PubMed
Background Well-differentiated neuroendocrine neoplasms (NENs) of the gastroenteropancreatic system are characterised by a low mutational burden and indolent tumour growth. These features contribute to the poor success rates of cytotoxic
Search for other papers by Wouter W de Herder in
Google Scholar
PubMed
Search for other papers by Günter Klöppel in
Google Scholar
PubMed
two hormones. This review is a sequel to the discovery of insulin and glucagon and introduces the history of this fascinating group of neuroendocrine neoplasms and hyperplasias of the pancreas. Pancreatic islets Pancreatic islet cells were
Search for other papers by Bora E Baysal in
Google Scholar
PubMed
Search for other papers by Eamonn R Maher in
Google Scholar
PubMed
Introduction Paragangliomas are neuroendocrine neoplasms that may arise from parasympathetic or sympathetic paraganglia. In general, those arising from parasympathetic paraganglia are non-secretory, associated with head and neck paraganglia and are
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetology and Clinical Nutrition, University Hospital Zurich, Zurich, Switzerland
Search for other papers by Ariadni Spyroglou in
Google Scholar
PubMed
Search for other papers by Stylianos Kykalos in
Google Scholar
PubMed
Endocrine Unit, First Department of Propaedeutic Medicine, Laiko University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Kosmas Daskalakis in
Google Scholar
PubMed
Search for other papers by Georgios Kyriakopoulos in
Google Scholar
PubMed
Search for other papers by Georgios C Sotiropoulos in
Google Scholar
PubMed
Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed
NET Unit, Royal Free Hospital, London, UK
Barts and the London School of Medicine, London, UK
Search for other papers by Ashley B Grossman in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are tumours which are relatively rare but have shown an ongoing increase in their annual age-adjusted incidence, from 1.09/100,000 persons in 1973 to 6.98/100,000 persons in 2012, according to the
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Vivian Rosery in
Google Scholar
PubMed
Search for other papers by Henning Reis in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Konstantinos Savvatakis in
Google Scholar
PubMed
Search for other papers by Bernd Kowall in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Martin Stuschke in
Google Scholar
PubMed
General, Visceral and Transplantation Surgery, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Search for other papers by Andreas Paul in
Google Scholar
PubMed
Department of Internal Medicine 6, Paracelsus Medical University, Nürnberg, Germany
Search for other papers by Alexander Dechêne in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by JiaJin Yang in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Ben Zhao in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Arianna Borgers in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Stefan Kasper in
Google Scholar
PubMed
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Martin Schuler in
Google Scholar
PubMed
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
Search for other papers by Phyllis F Cheung in
Google Scholar
PubMed
Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
Division of Solid Tumor Translational Oncology, German Cancer Consortium (DKTK), Partner site University Hospital Essen, and German Cancer Research Center (DKFZ), Heidelberg, Germany
German Cancer Consortium (DKTK), Partner site University Hospital Essen, Essen, Germany
Search for other papers by Jens T Siveke in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NEN) are epithelial malignancies with neuroendocrine differentiation. According to the WHO classification 2010, NEN of the gastrointestinal tract are classified based on their morphology and proliferative
Search for other papers by Sten Myrehaug in
Google Scholar
PubMed
Search for other papers by David L Chan in
Google Scholar
PubMed
Search for other papers by Victor Rodriguez-Freixinos in
Google Scholar
PubMed
Search for other papers by Hans Chung in
Google Scholar
PubMed
Search for other papers by Julie Hallet in
Google Scholar
PubMed
Search for other papers by Calvin Law in
Google Scholar
PubMed
Search for other papers by Chirag Patel in
Google Scholar
PubMed
Search for other papers by Laurent Milot in
Google Scholar
PubMed
Search for other papers by John Hudson in
Google Scholar
PubMed
Search for other papers by Hanbo Chen in
Google Scholar
PubMed
Search for other papers by Simron Singh in
Google Scholar
PubMed
management of neuroendocrine neoplasms . Journal of Clinical Oncology 38 (4 supplement) 616 – 616 . ( https://doi.org/10.1200/JCO.2020.38.4_suppl.616 ) Chen K Lawhn-Heath C Behr S Juarez R Whitman J Paciorek A Nakakura E Fidelman N Uan
Department of Biomedical Sciences, Cluster for Molecular Imaging, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Esben Andreas Carlsen in
Google Scholar
PubMed
Search for other papers by Nicola Fazio in
Google Scholar
PubMed
Search for other papers by Dan Granberg in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Search for other papers by Hojjat Ahmadzadehfar in
Google Scholar
PubMed
Search for other papers by Chiara Maria Grana in
Google Scholar
PubMed
Search for other papers by Wouter T Zandee in
Google Scholar
PubMed
Search for other papers by Jaroslaw Cwikla in
Google Scholar
PubMed
Search for other papers by Martin A Walter in
Google Scholar
PubMed
Search for other papers by Peter Sandor Oturai in
Google Scholar
PubMed
Search for other papers by Anja Rinke in
Google Scholar
PubMed
Search for other papers by Andrew Weaver in
Google Scholar
PubMed
Search for other papers by Andrea Frilling in
Google Scholar
PubMed
Search for other papers by Sara Gritti in
Google Scholar
PubMed
Search for other papers by Anne Kirstine Arveschoug in
Google Scholar
PubMed
Search for other papers by Amichay Meirovitz in
Google Scholar
PubMed
Departments of Surgical Gastroenterology and Clinical Endocrinology, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Ulrich Knigge in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Halfdan Sorbye in
Google Scholar
PubMed
Introduction Neuroendocrine neoplasms (NENs) are a very heterogeneous entity classified according to primary tumor location, stage, proliferation rate and differentiation. The 2010 World Health Organization (WHO) Classification grades NEN
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Search for other papers by Gregory A Kaltsas in
Google Scholar
PubMed
Search for other papers by Simona Grozinsky-Glasberg in
Google Scholar
PubMed
Introduction Pancreatic neuroendocrine neoplasms (panNENs) are considered rare malignancies despite a steady increase in their incidence as shown by recent epidemiological studies ( Dasari et al. 2017 ). PanNENs are considered slow